Guggenheim Capital’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Buy |
37,912
+1,209
| +3% | +$39.9K | 0.01% | 803 |
|
|
2025
Q1 | $1.48M | Buy |
36,703
+715
| +2% | +$28.7K | 0.01% | 730 |
|
|
2024
Q4 | $1.69M | Sell |
35,988
-4,898
| -12% | -$230K | 0.01% | 708 |
|
|
2024
Q3 | $2.16M | Sell |
40,886
-234
| -0.6% | -$12.4K | 0.02% | 800 |
|
|
2024
Q2 | $2.23M | Sell |
41,120
-548
| -1% | -$29.7K | 0.02% | 779 |
|
|
2024
Q1 | $2.92M | Sell |
41,668
-2,554
| -6% | -$179K | 0.02% | 750 |
|
|
2023
Q4 | $3.69M | Sell |
44,222
-6,780
| -13% | -$566K | 0.03% | 629 |
|
|
2023
Q3 | $1.5M | Sell |
51,002
-1,173
| -2% | -$34.6K | 0.01% | 922 |
|
|
2023
Q2 | $1.7M | Buy |
52,175
+1,219
| +2% | +$39.8K | 0.01% | 928 |
|
|
2023
Q1 | $1.79M | Sell |
50,956
-7,756
| -13% | -$273K | 0.02% | 887 |
|
|
2022
Q4 | $2.69M | Buy |
58,712
+22,670
| +63% | +$1.04M | 0.02% | 739 |
|
|
2022
Q3 | $1.75M | Buy |
+36,042
| New | +$1.75M | 0.02% | 886 |
|
|
2021
Q2 | – | Sell |
-9,410
| Closed | -$219K | – | 2190 |
|
|
2021
Q1 | $219K | Sell |
9,410
-9,365
| -50% | -$218K | ﹤0.01% | 2056 |
|
|
2020
Q4 | $390K | Buy |
+18,775
| New | +$390K | ﹤0.01% | 1737 |
|
|
2017
Q4 | – | Sell |
-123,456
| Closed | -$1.79M | – | 2731 |
|
|
2017
Q3 | $1.79M | Buy |
123,456
+10,201
| +9% | +$148K | ﹤0.01% | 1750 |
|
|
2017
Q2 | $1.37M | Buy |
+113,255
| New | +$1.37M | ﹤0.01% | 1882 |
|
|
2014
Q3 | – | Sell |
-17,607
| Closed | -$84K | – | 2968 |
|
|
2014
Q2 | $84K | Sell |
17,607
-290
| -2% | -$1.38K | ﹤0.01% | 2984 |
|
|
2014
Q1 | $170K | Buy |
17,897
+5,262
| +42% | +$50K | ﹤0.01% | 2870 |
|
|
2013
Q4 | $82K | Buy |
12,635
+1,693
| +15% | +$11K | ﹤0.01% | 2946 |
|
|
2013
Q3 | $83K | Buy |
+10,942
| New | +$83K | ﹤0.01% | 2813 |
|